Hala Abou El Naja
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hala Abou El Naja has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Majd Saleh
London School of Hygiene and Tropical Medicine, Department of Global Health and Development, 15–17 Tavistock Place, London WC1H 9SH, UK
3 shared publications - Nada Ghosn
Epidemiological Surveillance Program, Ministry of Public Health, Beirut 0127, Lebanon
3 shared publications - Zeina Farah
Epidemiological Surveillance Program, Lebanon Ministry of Public Health, Beirut, Lebanon
3 shared publications - Pamela Mrad
Lebanon Country Office, World Health Organization, Beirut 2832, Lebanon
2 shared publications - Hannah Eleanor Clapham
Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore
1 shared publication - Lina Chaito
Epidemiological Surveillance Program, Ministry of Public Health, Beirut 0127, Lebanon
1 shared publication
Latest Publications
- Open Access
- 3 July 2023
- Published by MDPI AG in Epidemiologia
- Vol. 4 (3) , 255-266
Communicable Disease Surveillance in Lebanon during the Syrian Humanitarian Crisis, 2013–2019
Lebanon has been one of the most affected countries by the Syrian humanitarian crisis. The national communicable disease surveillance was enhanced to detect outbreaks among Syrians. In this study, we aim to describe the findings of the communicable disease surveillance among Syrians in Lebanon, compare it to residents’ data, and describe the implemented surveillance activities between 2013 and 2019. During the study period, data on communicable diseases was mainly collected through the routine national surveillance system and an enhanced syndromic surveillance system. Predefined case definitions and standard operating procedures were in place. Data collection included both case-based and disease-specific reporting forms. Descriptive data and incidence rates were generated. Information was disseminated through weekly reports. Activities were conducted in close collaboration with different partners. The most commonly reported diseases were: viral hepatitis A, cutaneous leishmaniasis, mumps, and measles. Hepatitis A incidence increased in 2013 and 2014 among Syrians as well as residents. For leishmaniasis, the incidence increased only among Syrians in 2013 and decreased after that. An outbreak of mumps was reported among Syrians between 2014 and 2016, with a peak in 2015 concomitant with a national outbreak. Outbreaks of measles were reported among Syrians and residents in 2013, 2018, and 2019. The infrastructure of the well-implemented surveillance system in Lebanon has been utilized to monitor the health status of Syrians in Lebanon, early detect communicable diseases among this population, and guide needed preventive and control measures. This highlights the importance of having a flexible surveillance system that can be adapted to emergencies and the importance of sharing results with involved partners.
- 3 July 2023
- Published by MDPI AG in Epidemiologia
- Vol. 4 (3) , 255-266
Open AccessCommunicable Disease Surveillance in Lebanon during the Syrian Humanitarian Crisis, 2013–2019
Lebanon has been one of the most affected countries by the Syrian humanitarian crisis. The national communicable disease surveillance was enhanced to detect outbreaks among Syrians. In this study, we aim to describe the findings of the communicable disease surveillance among Syrians in Lebanon, compare it to residents’ data, and describe the implemented surveillance activities between 2013 and 2019. During the study period, data on communicable diseases was mainly collected through the routine national surveillance system and an enhanced syndromic surveillance system. Predefined case definitions and standard operating procedures were in place. Data collection included both case-based and disease-specific reporting forms. Descriptive data and incidence rates were generated. Information was disseminated through weekly reports. Activities were conducted in close collaboration with different partners. The most commonly reported diseases were: viral hepatitis A, cutaneous leishmaniasis, mumps, and measles. Hepatitis A incidence increased in 2013 and 2014 among Syrians as well as residents. For leishmaniasis, the incidence increased only among Syrians in 2013 and decreased after that. An outbreak of mumps was reported among Syrians between 2014 and 2016, with a peak in 2015 concomitant with a national outbreak. Outbreaks of measles were reported among Syrians and residents in 2013, 2018, and 2019. The infrastructure of the well-implemented surveillance system in Lebanon has been utilized to monitor the health status of Syrians in Lebanon, early detect communicable diseases among this population, and guide needed preventive and control measures. This highlights the importance of having a flexible surveillance system that can be adapted to emergencies and the importance of sharing results with involved partners.
- Open Access
- 14 June 2023
- Published by MDPI AG in Epidemiologia
- Vol. 4 (2) , 212-222
Effectiveness of the Pfizer-BioNTech Vaccine against COVID-19-Associated Hospitalizations among Lebanese Adults ≥75 Years Old—Lebanon, April–May 2021
In Lebanon, the nationwide vaccination against COVID-19 was launched in February 2021 using the Pfizer-BioNTech vaccine and prioritizing elderly people, persons with comorbidities, and healthcare workers. Our study aims to estimate the post-introduction vaccine effectiveness (VE) of the Pfizer-BioNTech vaccine in preventing COVID-19 hospitalizations among elderly people ≥75 years old in Lebanon. A case–control study design was used. Case patients were Lebanese, ≥75 years old, and hospitalized with positive PCR results during April–May 2021, and randomly selected from the database of the Epidemiological Surveillance Unit at the Ministry of Public Health (MOPH). Each case patient was matched by age and locality to two controls. The controls were hospitalized, non-COVID-19 patients, randomly selected from the MOPH hospital admission database. VE was calculated for fully (2 doses ≥14 days) and partially vaccinated (≥14 days of the first or within 14 days of the second dose) participants using multivariate logistic regression. A total of 345 case patients and 814 controls were recruited. Half were females, with a mean age of 83 years. A total of 14 case patients (5%) and 143 controls (22%) were fully vaccinated. A bivariate analysis showed a significant association with gender, month of confirmation/hospital admission, general health, chronic medical conditions, main income source, and living arrangement. After adjusting for a month of hospital admission and gender, the multivariate analysis yielded a VE of 82% (95% CI = 69–90%) against COVID-19-associated hospitalizations for those fully vaccinated and 53% (95% CI = 23–71%) for those partially vaccinated. Our study shows that the Pfizer-BioNTech vaccine is effective in reducing the risk for COVID-19-associated hospitalizations of Lebanese elderly people (≥75 years old). Additional studies are warranted to explore VE in reducing hospitalizations for younger age groups, as well as reducing COVID-19 infections.
- 14 June 2023
- Published by MDPI AG in Epidemiologia
- Vol. 4 (2) , 212-222
Open AccessEffectiveness of the Pfizer-BioNTech Vaccine against COVID-19-Associated Hospitalizations among Lebanese Adults ≥75 Years Old—Lebanon, April–May 2021
In Lebanon, the nationwide vaccination against COVID-19 was launched in February 2021 using the Pfizer-BioNTech vaccine and prioritizing elderly people, persons with comorbidities, and healthcare workers. Our study aims to estimate the post-introduction vaccine effectiveness (VE) of the Pfizer-BioNTech vaccine in preventing COVID-19 hospitalizations among elderly people ≥75 years old in Lebanon. A case–control study design was used. Case patients were Lebanese, ≥75 years old, and hospitalized with positive PCR results during April–May 2021, and randomly selected from the database of the Epidemiological Surveillance Unit at the Ministry of Public Health (MOPH). Each case patient was matched by age and locality to two controls. The controls were hospitalized, non-COVID-19 patients, randomly selected from the MOPH hospital admission database. VE was calculated for fully (2 doses ≥14 days) and partially vaccinated (≥14 days of the first or within 14 days of the second dose) participants using multivariate logistic regression. A total of 345 case patients and 814 controls were recruited. Half were females, with a mean age of 83 years. A total of 14 case patients (5%) and 143 controls (22%) were fully vaccinated. A bivariate analysis showed a significant association with gender, month of confirmation/hospital admission, general health, chronic medical conditions, main income source, and living arrangement. After adjusting for a month of hospital admission and gender, the multivariate analysis yielded a VE of 82% (95% CI = 69–90%) against COVID-19-associated hospitalizations for those fully vaccinated and 53% (95% CI = 23–71%) for those partially vaccinated. Our study shows that the Pfizer-BioNTech vaccine is effective in reducing the risk for COVID-19-associated hospitalizations of Lebanese elderly people (≥75 years old). Additional studies are warranted to explore VE in reducing hospitalizations for younger age groups, as well as reducing COVID-19 infections.
- Open Access
- 11 October 2021
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 21 (1) , 1-6
Calculating the serial interval of SARS-CoV-2 in Lebanon using 2020 contact-tracing data
Introduction: The first detected case in Lebanon on 21 February 2020 engendered implementation of a nationwide lockdown alongside timely contact-tracing and testing. Objectives: Our study aims to calculate the serial interval of SARS-CoV-2 using contact tracing data collected 21 February to 30 June 2020 in Lebanon to guide testing strategies. Methods: rRT-PCR positive COVID-19 cases reported to the Ministry of Public Health Epidemiological Surveillance Program (ESU-MOH) are rapidly investigated and identified contacts tested. Positive cases and contacts assigned into chains of transmission during the study time-period were verified to identify those symptomatic, with non-missing date-of-onset and reported source of exposure. Selected cases were classified in infector–infectee pairs. We calculated mean and standard deviation for the serial interval and best distribution fit using AIC criterion. Results: Of a total 1788 positive cases reported, we included 103 pairs belonging to 24 chains of transmissions. Most cases were Lebanese (98%) and male (63%). All infectees acquired infection locally. Mean serial interval was 5.24 days, with a standard deviation of 3.96 and a range of − 4 to 16 days. Normal distribution was an acceptable fit for our non-truncated data. Conclusion: Timely investigation and social restriction measures limited recall and reporting biases. Pre-symptomatic transmission up to 4 days prior to symptoms onset was documented among close contacts. Our SI estimates, in line with international literature, provided crucial information that fed into national contact tracing measures. Our study, demonstrating the value of contact-tracing data for evidence-based response planning, can help inform national responses in other countries.
- 11 October 2021
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 21 (1) , 1-6
Open AccessCalculating the serial interval of SARS-CoV-2 in Lebanon using 2020 contact-tracing data
Introduction: The first detected case in Lebanon on 21 February 2020 engendered implementation of a nationwide lockdown alongside timely contact-tracing and testing. Objectives: Our study aims to calculate the serial interval of SARS-CoV-2 using contact tracing data collected 21 February to 30 June 2020 in Lebanon to guide testing strategies. Methods: rRT-PCR positive COVID-19 cases reported to the Ministry of Public Health Epidemiological Surveillance Program (ESU-MOH) are rapidly investigated and identified contacts tested. Positive cases and contacts assigned into chains of transmission during the study time-period were verified to identify those symptomatic, with non-missing date-of-onset and reported source of exposure. Selected cases were classified in infector–infectee pairs. We calculated mean and standard deviation for the serial interval and best distribution fit using AIC criterion. Results: Of a total 1788 positive cases reported, we included 103 pairs belonging to 24 chains of transmissions. Most cases were Lebanese (98%) and male (63%). All infectees acquired infection locally. Mean serial interval was 5.24 days, with a standard deviation of 3.96 and a range of − 4 to 16 days. Normal distribution was an acceptable fit for our non-truncated data. Conclusion: Timely investigation and social restriction measures limited recall and reporting biases. Pre-symptomatic transmission up to 4 days prior to symptoms onset was documented among close contacts. Our SI estimates, in line with international literature, provided crucial information that fed into national contact tracing measures. Our study, demonstrating the value of contact-tracing data for evidence-based response planning, can help inform national responses in other countries.
- Open Access
- 1 January 2020
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 36
Acute flaccid paralysis (AFP) surveillance system in Lebanon: a teaching case-study
Lebanon has been declared polio-free since 2002. In 2003, following an imported polio case, national campaigns succeeded to contain the virus with no further cases. Since 2013, the risk of poliovirus importation became concrete. Several risk factors linked to the Syrian crisis were illustrated including wild poliovirus type 1 outbreak in Syria in 2013-2014, huge Syrian population influx into Lebanon due to insecurity, and circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreak in Syria in 2017. Hence, there is continuous need to enhance Acute Flaccid Paralysis (AFP) surveillance to timely detect any imported poliovirus for the implementation of needed response. The goal of the case study is to build the capacity of Field Epidemiology Training Program (FETP) residents and other health professionals in the area of AFP reporting and prepare health care staff to any polio importation into the country. This case study is can be administered in 2-3 hours.
- 1 January 2020
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 36
Open AccessAcute flaccid paralysis (AFP) surveillance system in Lebanon: a teaching case-study
Lebanon has been declared polio-free since 2002. In 2003, following an imported polio case, national campaigns succeeded to contain the virus with no further cases. Since 2013, the risk of poliovirus importation became concrete. Several risk factors linked to the Syrian crisis were illustrated including wild poliovirus type 1 outbreak in Syria in 2013-2014, huge Syrian population influx into Lebanon due to insecurity, and circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreak in Syria in 2017. Hence, there is continuous need to enhance Acute Flaccid Paralysis (AFP) surveillance to timely detect any imported poliovirus for the implementation of needed response. The goal of the case study is to build the capacity of Field Epidemiology Training Program (FETP) residents and other health professionals in the area of AFP reporting and prepare health care staff to any polio importation into the country. This case study is can be administered in 2-3 hours.